SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.

Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using ...

An increase in physical activity between the ages of 45 and 65 could help prevent Alzheimer's disease, while inactivity may ...

Americans are eager for early diagnosis and treatment and would accept some risk with taking medication to slow the ...

Key Takeaways Most Americans want to know in advance if they’re going to develop Alzheimer’s diseaseAbout 4 out of 5 want to ...

A survey of 1700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer's.

In the past, most studies focused on two main ideas about what triggers Alzheimer’s. One idea is that a sticky protein called ...

A new survey from the Alzheimer's Association finds that people want to know if they are in the early stages of the disease, and are open to drug treatment.

The new report shows prevalence, disease-related deaths and cost of caring for those living with Alzheimer’s are rising ...

Gene Hackman had "severe" heart disease and Alzheimer's disease when he died, according to his autopsy report. His wife died ...

The Alzheimer’s Association’s 2025 facts and figures report, which was released on Tuesday, shows that 7.2 million people in ...